TY  - GEN
AU  - Franceschi,Enrico
AU  - Lamberti,Giuseppe
AU  - Paccapelo,Alexandro
AU  - Di Battista,Monica
AU  - Genestreti,Giovenzio
AU  - Minichillo,Santino
AU  - Mura,Antonella
AU  - Bartolini,Stefania
AU  - Agati,Raffaele
AU  - Brandes,Alba A
TI  - Third-line therapy in recurrent glioblastoma: is it another chance for bevacizumab?
SN  - 1573-7373
PY  - 2019///0318
KW  - Acetanilides
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents, Immunological
KW  - adverse effects
KW  - Bevacizumab
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Brain Neoplasms
KW  - drug therapy
KW  - DNA Methylation
KW  - DNA Modification Methylases
KW  - DNA Repair Enzymes
KW  - Female
KW  - Follow-Up Studies
KW  - Glioblastoma
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Pyrroles
KW  - Quinolines
KW  - Retreatment
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - Tumor Suppressor Proteins
KW  - Young Adult
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1007/s11060-018-2873-x
ER  -